wes ely Archives

VUMC well represented at Association of American Medical Colleges annual meeting

Dec. 14, 2022—Several Vanderbilt University Medical Center faculty were featured in the annual meeting of the Association of American Medical Colleges in Nashville.

E. Wesley Ely, MD, MPH, speaks at last week’s Vanderbilt Translational Research Forum.

Translational Research Forum highlights range of studies

Oct. 27, 2022—The 2022 Vanderbilt Translational Research Forum exemplified the range of studies conducted at Vanderbilt University Medical Center that are translating scientific discovery into clinical practice.

PHOTO: Award recipients and presenters gather after Thursday’s State of the Department of Medicine address. From left are Brian Lindman, MD, MSCI, Alexandra Shingina, MD, MHS, Claude Shackelford, MD, Jill Gilbert, MD, Todd Hulgan, MD, MPH, Brian Christman, MD, Kimryn Rathmell, MD, PhD, Ambra Pozzi, PhD, T. Alp Ikizler, MD, Maie El-Sourady, MD, Walter Clair, MD, MPH, and Ana Nobis, MD, MPH. (photo by Susan Urmy)

Inclusivity key to Department of Medicine: Rathmell

Jun. 27, 2022—Commitment to inclusion, professional development, research, and clinical care was the focus of this year’s State of the Department of Medicine address delivered June 23 by Department of Medicine Chair Kimryn Rathmell, MD, PhD.

VUMC faculty members attending the meeting of the American Society for Clinical Investigation included, from left, Wesley Ely, MD, MPH, Patrick Hu, MD, PhD, Lorraine Ware, MD, Kimryn Rathmell, MD, PhD, Consuelo Wilkins, MD, MSCI, Christopher Williams, MD, PhD, Lori Jordan, MD, PhD, Natasha Halasa, MD, MPH, ASCI Council Member Julie Bastarache, MD, Eric Tkaczyk, MD, PhD, and James Crowe Jr., MD.

VUMC a national leader in physician-scientist training

Apr. 21, 2022—Physician-scientists from Vanderbilt University Medical Center were well represented at the recent annual meeting of the American Society for Clinical Investigation (ASCI), Association of American Physicians (AAP) and the American Physician-Scientist Association.

Study shows life-saving benefit of baricitinib for ventilated COVID patients

Feb. 7, 2022—Vanderbilt research shows that critically ill COVID-19 patients on a mechanical ventilator or extracorporeal membrane oxygenation lived more often when randomized to receive baricitinib.

Rheumatoid arthritis drug combined with standard of care may help reduce mortality for hospitalized COVID-19 patients

Sep. 2, 2021—Hospitalized patients with COVID-19 who received the rheumatoid arthritis drug baricitinib, in combination with the standard of care including corticosteroids, died less often than those receiving only the standard of care, according to a study released this week in The Lancet Respiratory Medicine.

The study team includes, from left, Douglas Heimburger, MD, MS, Kondwelani Mateyo, MBChB, MMed, Justin Banerdt, MD, MPH, and E. Wesley Ely, MD.

Vanderbilt, Zambia researchers identify predictive factors of delirium in Sub-Saharan Africa

Apr. 22, 2021—Severity of illness, history of stroke, and being divorced or widowed were independently predictive of delirium in hospitalized patients in Zambia, according to a study published in PLOS ONE.

Vanderbilt, Zambia researchers find delirium in hospitalized patients linked to mortality, disability in Sub-Saharan Africa

Feb. 11, 2021—Delirium, a form of acute brain dysfunction, is widespread in critically ill patients in lower resourced hospitals, and the duration of delirium predicted both mortality and disability at six months after discharge, according to a study published in PLOS ONE.

Interventions such as daily spontaneous waking trials can help patients avoid injuries associated with intensive care.

Study to test cognitive rehab therapy for ICU survivors

May. 27, 2020—Vanderbilt University Medical Center will study adult survivors of medical and surgical intensive care at high risk for long-term cognitive impairment to see if computerized cognitive rehabilitation (CCR) is effective in improving cognition in ICU survivors who often have trouble doing complex tasks, maintaining their finances and staying employed.

New software aims to prevent intensive care unit delirium

Jan. 8, 2020—Intensive care unit delirium, a fertile area of clinical research and patient care innovation associated with VUMC, is beginning to reshape how commercial electronic health record systems are engineered with regard to intensive care.

Antipsychotics ineffective for treating ICU delirium: study

Oct. 22, 2018—Critically ill patients are not benefiting from antipsychotic medications that have been used to treat delirium in intensive care units (ICUs) for more than four decades, according to a study released today in the New England Journal of Medicine.

New center formed to treat, study ICU delirium, dementia

Oct. 4, 2018—Millions of patients in intensive care units each year develop delirium during their hospitalization and often leave the hospital with cognitive deficits similar to those suffering from traumatic brain injury or mild Alzheimer’s disease.

VUMC Reporter